Biomanufacturing Viral Detection and Quantification Market Report on the Untapped Growth Opportunities in the Industry

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Biomanufacturing Viral Detection and Quantification Market Size, Share & Trends Analysis Report By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, and Others), By Application (Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing), By End User (Life Science Companies, Testing Laboratories, CROs and CDMOs) Market Outlook And Industry Analysis 2031"

According to the latest research by InsightAce Analytic, the global Biomanufacturing Viral Detection and Quantification Market size is valued at US$ 466.52 Million in 2022, and it is expected to reach US$ 981.41 Million in 2031, recording a promising CAGR of 8.8% during the forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1918

Viral detection and quantification are critical components in biomanufacturing processes, especially when viruses serve as active pharmaceutical ingredients. These procedures involve the precise analysis and measurement of viral loads within the large-scale production of biological products, including vaccines, therapeutic proteins, and viral vectors. Accurate viral monitoring ensures product consistency, quality, and safety throughout the manufacturing lifecycle. The selection of detection and quantification methods is tailored to meet the specific requirements of each biomanufacturing process.

Biological therapies are inherently susceptible to contamination by bacteria, fungi, and viruses, which poses significant risks to production timelines and ultimately impacts healthcare delivery. Early identification of such contaminants
is essential to mitigate production delays and maintain operational efficiency.

Some of the prominent players in the Biomanufacturing Viral Detection and Quantification Market are:
• Danaher Corporation
• Merck KGaA
• New England Biolabs
• TAKARA HOLDINGS INC.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Genscript Biotech Corporation
• Norgen Biotek Corp.
• Other Prominent Players

Market Dynamics:
Drivers:
The biomanufacturing viral detection and quantification market is propelled by several key factors, including the rapid advancement of technologies aimed at improving the detection and measurement of viral contaminants, the expanding adoption of biopharmaceuticals, the growing emphasis on stringent quality control (QC) protocols, and continuous innovations in viral testing methodologies.

Increasing usage of biopharmaceuticals:
The quality of biopharmaceutical products is ensured through viral detection and quantification, which is essential to biopharmaceutical industries. QC (Quality Control) measures are necessary to maintain the safety, efficacy and consistency of biopharmaceuticals. Thus, the demand for viral testing technologies is increasing, surging the growth opportunities for the biomanufacturing viral detection and quantification market.

Advancements in viral testing technologies:
The development of assays such as polymerase chain reaction (PCR) and real-time PCR (qPCR) allows rapid and accurate virus detection by measuring the nucleic acid of the virus with certain accuracy and sensitivity.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1918

Challenges:
Market growth may be constrained by the high capital investment required for advanced viral detection instrumentation and the shortage of skilled personnel capable of operating and interpreting complex testing systems.

Regional Trends:
North America is anticipated to maintain a dominant market share throughout the forecast period, driven by robust demand for biological therapies, progressive advancements in contaminant detection technologies, and substantial government funding aimed at optimizing biomanufacturing processes.

Concurrently, the Asia Pacific region is expected to experience the fastest growth rate, supported by an increasing number of biopharmaceutical companies, well-developed industrial infrastructure, government initiatives to enhance product quality, ongoing innovation in cell and gene therapies, and the expanding capabilities of contract manufacturing organizations within the region.

Key Developments In The Market:
• In September 2019, Merck KGaA partnered with Pfizer Inc. and launched a new drug BAVENCIO for t[the removal of viruses.
• In July 2018, Diversigen Inc. and Norgen Biotek Corp. entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses.
• In July 2016, Sartorius acquired ViroCyt for $16 million to expand the buyer's lab products and services offerings by adding the developer of rapid virus quantification tools. The deal is Sartorius' second tools acquisition in less than 3 weeks. On June 28, Sartorius signaled its expansion into bioanalytics by purchasing cell screening platforms developer IntelliCyt for $90 million.

Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/1918

Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Offering Type
• Consumables
• Instruments
• Services
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology
• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application
• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End User
• Life Science Companies
• Testing Laboratories
• CROs and CDMOs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Get More Information :
https://www.insightaceanalytic.com/report/biomanufacturing-viral-detection-and-quantification-market/1918

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.